| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |